These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 3932508

  • 21. [Congenital nonhemolytic hyperbilirubinemia].
    Casanueva V, Marín O, Calvo C, Cid X, Muñoz M.
    Rev Chil Pediatr; 1983; 54(5):344-9. PubMed ID: 6424183
    [No Abstract] [Full Text] [Related]

  • 22. Reduction of hyperbilirubinemia with hypericum extract (St. John's Wort) in a patient with Crigler-Najjar syndrome type II.
    Kummer O, Hammann F, Haschke M, Krähenbühl S.
    Br J Clin Pharmacol; 2016 May; 81(5):1002-4. PubMed ID: 26692114
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Delayed response to phenobarbital treatment of a Crigler-Najjar type II patient with partially inactivating missense mutations in the bilirubin UDP-glucuronosyltransferase gene.
    Ciotti M, Werlin SL, Owens IS.
    J Pediatr Gastroenterol Nutr; 1999 Feb; 28(2):210-3. PubMed ID: 9932859
    [No Abstract] [Full Text] [Related]

  • 26. The presence of a microsomal UDP-glucuronyl transferase for bilirubin in homozygous jaundiced Gunn rats and in the Crigler-Najjar syndrome.
    Odell GB, Cukier JO, Gourley GR.
    Hepatology; 1981 Feb; 1(4):307-15. PubMed ID: 6793495
    [Abstract] [Full Text] [Related]

  • 27. Crigler-Najjar type II disease inheritance: a family study.
    Labrune P, Myara A, Hennion C, Gout JP, Trivin F, Odievre M.
    J Inherit Metab Dis; 1989 Feb; 12(3):302-6. PubMed ID: 2515370
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.
    Ciotti M, Chen F, Rubaltelli FF, Owens IS.
    Biochim Biophys Acta; 1998 Jul 01; 1407(1):40-50. PubMed ID: 9639672
    [Abstract] [Full Text] [Related]

  • 30. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.
    Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR.
    Hum Mutat; 2000 Oct 01; 16(4):297-306. PubMed ID: 11013440
    [Abstract] [Full Text] [Related]

  • 31. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.
    Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP.
    N Engl J Med; 1995 Nov 02; 333(18):1171-5. PubMed ID: 7565971
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Bilirubin metabolism. Review and discussion of inborn errors.
    Valaes T.
    Clin Perinatol; 1976 Mar 02; 3(1):177-209. PubMed ID: 821690
    [No Abstract] [Full Text] [Related]

  • 35. Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences.
    Erlinger S, Arias IM, Dhumeaux D.
    Gastroenterology; 2014 Jun 02; 146(7):1625-38. PubMed ID: 24704527
    [Abstract] [Full Text] [Related]

  • 36. Crigler-Najjar syndrome type II caused by a homozygous triple mutation [T-3279G, A(TA)7TAA, and H39D] of UGT1A1.
    Maruo Y, Topaloglu AK, Takahashi H, Mori A, Iwai M, Duzovali O, Yamamoto K, Matui K, Sato H, Takeuchi Y.
    J Pediatr Gastroenterol Nutr; 2006 Feb 02; 42(2):236-9. PubMed ID: 16456422
    [No Abstract] [Full Text] [Related]

  • 37. Orlistat treatment of unconjugated hyperbilirubinemia in Crigler-Najjar disease: a randomized controlled trial.
    Hafkamp AM, Nelisse-Haak R, Sinaasappel M, Oude Elferink RP, Verkade HJ.
    Pediatr Res; 2007 Dec 02; 62(6):725-30. PubMed ID: 17957158
    [Abstract] [Full Text] [Related]

  • 38. Fenofibrate treatment in two adults with Crigler-Najjar syndrome type II.
    Yilmaz S, Dursun M, Canoruç F, Kidir V, Beştaş R.
    Turk J Gastroenterol; 2006 Mar 02; 17(1):62-5. PubMed ID: 16830281
    [Abstract] [Full Text] [Related]

  • 39. Type II crigler-Najjar syndrome with intrahepatic cholestasis.
    Kagita A, Adachi Y, Kambe A, Kamisako T, Yamamoto T.
    J Gastroenterol; 1994 Apr 02; 29(2):214-7. PubMed ID: 8012512
    [Abstract] [Full Text] [Related]

  • 40. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase.
    Askari FK, Hitomi Y, Mao M, Wilson JM.
    Gene Ther; 1996 May 02; 3(5):381-8. PubMed ID: 9156798
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.